Perspective: SBI2 at Its Fifth Annual Meeting
Drug Repurposing Patent Applications January–March 2018
Changes on the Horizon for Drug Repurposing, Rescue, and Repositioning at ASSAY
Ebselen Reversibly Inhibits Human Glutamate Dehydrogenase at the Catalytic Site
Know When You Don't Know: A Robust Deep Learning Approach in the Presence of Unknown Phenotypes
Integration of Antibody Array Technology into Drug Discovery and Development